These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33933820)

  • 41. Idiopathic orbital myositis presenting as cluster headache: a case report.
    Ersoy A; Soyturk M
    Acta Neurol Belg; 2017 Dec; 117(4):937-939. PubMed ID: 28342020
    [No Abstract]   [Full Text] [Related]  

  • 42. A unique case of foreign-body associated orbital myositis.
    Lee S; Shetlar DJ; Yen MT
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):e80-2. PubMed ID: 22082591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The involvement of tendons in IgG4-related diffuse orbital myositis.
    Zhang Y; Zhang Y
    J Clin Neurosci; 2022 Jul; 101():278-279. PubMed ID: 35667996
    [No Abstract]   [Full Text] [Related]  

  • 44. Orbital myositis in Behçet's disease.
    Chebbi W; Jerbi S; Ammari W; Younes M; Sfar MH
    Joint Bone Spine; 2014 May; 81(3):264. PubMed ID: 24326194
    [No Abstract]   [Full Text] [Related]  

  • 45. [Oral steroids downgraded, biologics upgraded].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(10):86. PubMed ID: 27221447
    [No Abstract]   [Full Text] [Related]  

  • 46. Strict adherence rules to obtain monoclonal therapy might cost lives.
    Green RH; Shaw D
    Lancet Respir Med; 2017 Sep; 5(9):678-679. PubMed ID: 28666608
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab.
    Silkiss RZ; Paap MK; Roelofs KA; Agi J; Weis E
    Can J Ophthalmol; 2021 Feb; 56(1):66-70. PubMed ID: 32919997
    [No Abstract]   [Full Text] [Related]  

  • 48. Orbital myositis and psoriatic arthritis.
    Ssi-Yan-Kai I; Pearson A
    Can J Ophthalmol; 2012 Dec; 47(6):e42-3. PubMed ID: 23217511
    [No Abstract]   [Full Text] [Related]  

  • 49. [Successful management of recurrent bleeding with tocilizumab in an acquired hemophilia A patient with rheumatoid arthritis].
    Hashimoto A; Takafuta T; Kido M; Okikawa Y; Ito T
    Rinsho Ketsueki; 2017; 58(7):738-742. PubMed ID: 28781267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Orbital inflammatory disorders: new knowledge, future challenges.
    Kahana A
    Curr Opin Ophthalmol; 2021 May; 32(3):255-261. PubMed ID: 33606408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome.
    Murphy SM; Lilleker JB; Helliwell P; Chinoy H
    Rheumatology (Oxford); 2016 Dec; 55(12):2277-2278. PubMed ID: 27550295
    [No Abstract]   [Full Text] [Related]  

  • 53. Orbital Myositis: A Comprehensive Review and Reclassification.
    McNab AA
    Ophthalmic Plast Reconstr Surg; 2020; 36(2):109-117. PubMed ID: 31261163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orbital Myositis.
    Brent H; Sidlow R
    Clin Pediatr (Phila); 2017 Apr; 56(4):385-388. PubMed ID: 27462048
    [No Abstract]   [Full Text] [Related]  

  • 55. Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
    Langer-Gould A; Smith JB; Gonzales EG; Castillo RD; Figueroa JG; Ramanathan A; Li BH; Gould MK
    Int J Infect Dis; 2020 Oct; 99():291-297. PubMed ID: 32768693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tocilizumab in refractory juvenile idiopathic arthritis with associated uveitis: a case report.
    Sousa-Neves F; Braga J; Teixeira S; Barge S; Fonseca S; Meira D; Rodrigues L; Varandas R
    Acta Reumatol Port; 2019; 44(2):151-154. PubMed ID: 31455751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orbital compartment syndrome as the first manifestation of SLE.
    Colon M; El Khoury L
    Clin Rheumatol; 2020 Jul; 39(7):2223-2226. PubMed ID: 32152917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fronto-orbital tuberculous osteomyelitis with temporalis myositis.
    Sivaraju L; Saritha A; Atal A; Hegde AS
    Orbit; 2016 Jun; 35(3):161-2. PubMed ID: 27153182
    [No Abstract]   [Full Text] [Related]  

  • 59. Early tocilizumab treatment could improve survival among COVID-19 patients.
    Campins L; Boixeda R; Perez-Cordon L; Aranega R; Lopera C; Force L
    Clin Exp Rheumatol; 2020; 38(3):578. PubMed ID: 32456769
    [No Abstract]   [Full Text] [Related]  

  • 60. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.